Article

Michael Ferraro on His Mother's Pancreatic Cancer Journey

Author(s):

Michael Ferraro

Michael Ferraro, executive chef, Delicatessen, discusses his mother's journey with pancreatic cancer and his role in the Cooking. Comfort. Care. Nourishment for the Pancreatic Cancer Fight program.

Michael Ferraro, executive chef, Delicatessen, discusses his mother’s journey with pancreatic cancer and his role in the Cooking. Comfort. Care. Nourishment for the Pancreatic Cancer Fight program.

Newsletter

Stay up to date on cancer updates, research and education

Subscribe Now!
Related Videos
Daniel Jernazian, who beat cancer twice, credits his sports mindset for survival and calls it winning his ‘life World Championship’.
Patients in rural or underserved areas may have worse outcomes, highlighting the need for early support to address care access barriers.
Image of man with text.
Dr. Emre Yekedüz discusses how ASCO 2025 highlights precision medicine, biomarkers and the gut microbiome as keys to advancing kidney cancer care.
Dr. Breelyn Wilky stresses the importance of expert guidance and second opinions for patients with GIST, as treatment options continue to evolve rapidly.
Mark Daniels, 83, credits CAR T-cell therapy and compassionate care for helping him overcome lymphoma and endure the isolating treatment toll.
An early study of BGB-16673 for hard-to-treat leukemia found that side effects were manageable with no new safety concerns.
Image of woman with text.
Image of goy, and text.
Watch oncology dietitian Kenisha Parikh prepare creamy lentil soup, a soothing, protein-packed recipe to help ease side effects during treatment.
Related Content
Daraxonrasib has received breakthrough therapy designation from the FDA for KRAS G12+, previously treated, metastatic PDAC: © stock.adobe.com.
June 24th 2025

Daraxonrasib Gains FDA Status for Certain Metastatic Pancreatic Cancer

Ryan Scott
Daraxonrasib has received breakthrough therapy designation from the FDA for KRAS G12+, previously treated, metastatic pancreatic ductal adenocarcinoma.
Site Logo
May 16th 2019

Katie Couric: Advice to My Younger Self

Katie Kosko Kristie L. Kahl
In this week’s episode, we spoke with legendary broadcast journalist Katie Couric about serving as a cancer caregiver and her new initiative with Merck’s Your Cancer Game Plan, called “With Love, Me.”
Atebimetinib with modified chemo led to 94% 6-month survival rates in first-line pancreatic cancer: © stock.adobe.com.
June 18th 2025

Atebimetinib Combo Shows 94% 6-Month Survival in Pancreatic Cancer

Spencer Feldman
Atebimetinib with modified chemo led to 94% 6-month survival rates in first-line pancreatic cancer, with durable responses and a favorable safety profile.
William Ramshaw resides in the expansive Pacific Northwest. He is a six-year survivor of pancreatic cancer. Catch up on William’s blogs here!
June 13th 2025

Pancreatic Cancer Tried to Crash My Three Daughters’ Weddings

William Ramshaw
I was told I wouldn’t live to see my daughters’ weddings — but 12 years later, I’ve been there for two, and I’m holding out hope for the third.
From left: GAYLE S. JAMESON, M.S.N, ACNP-BC, AOCN, and ERIN PIERCE, M.S.N., APRN, FNP-C; PHOTOS BY AZULA RAUN
May 21st 2025

A Trailblazer in Oncology Nursing and Research

Erin Pierce, M.S.N., APRN, FNP-C
Gayle S. Jameson, M.S.N, ACNP-BC, AOCN, is a trailblazer whose expertise and compassion have made a profound impact on oncology care.
Enclosed is the 2025 Quarter 1 – COA Patient Advocacy Network News Bulletin: © stock.adobe.com.
May 16th 2025

2025 Quarter 1 – COA Patient Advocacy Network News Bulletin.

COA Patient Advocacy Network
Enclosed is the 2025 Quarter 1 – COA Patient Advocacy Network News Bulletin.